Chad Dalton
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- Crystallography and molecular interactions
Papers in
-
- Drug Solubulity and Delivery Systems 11
- Advanced Drug Delivery Systems 2
-
- Analytical Chemistry and Chromatography 4
- Co-authors
- Bruno C. Hancock (7 shared papers)Sophie‐Dorothée Clas (5 shared papers)Michael J. Pikal (1 shared paper)Sheri L. Shamblin (1 shared paper)Robert Hartman (1 shared paper)Elizabeth Kwong (1 shared paper)Robert M. Wenslow (1 shared paper)Narayan Variankaval (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)Pharmaceutical Research (2 papers)Pharmaceutical Development and Technology (2 papers)International Journal of Pharmaceutics (2 papers)Molecular Pharmaceutics (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Chad Dalton
14 papers receiving 546 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 256
- Physical and Theoretical Chemistry 118
- Spectroscopy 93
- Analytical Chemistry 52
- Materials Chemistry 236
Countries citing papers authored by Chad Dalton
This map shows the geographic impact of Chad Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad Dalton more than expected).
Fields of papers citing papers by Chad Dalton
This network shows the impact of papers produced by Chad Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad Dalton. The network helps show where Chad Dalton may publish in the future.
Co-authors
The 25 scholars most cited alongside Chad Dalton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 191 | |
| 2 | 2006 | 95 | |
| 3 | 1998 | 63 | |
| 4 | 2017 | 48 | |
| 5 | 1999 | 48 | |
| 6 | 1997 | 41 | |
| 7 | 2001 | 18 | |
| 8 | 2018 | 18 | |
| 9 | 2011 | 14 | |
| 10 | 2005 | 14 | |
| 11 | 1999 | 11 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2013 | 0 |
About Chad Dalton
Chad Dalton is a scholar working on Pharmaceutical Science, Spectroscopy, Food Science, Materials Chemistry and Molecular Biology, having authored 15 papers that have together received 584 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (11 papers), Analytical Chemistry and Chromatography (4 papers), Crystallization and Solubility Studies (4 papers), Microencapsulation and Drying Processes (3 papers), Protein purification and stability (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Advanced Drug Delivery Systems (2 papers) and Crystallography and molecular interactions (2 papers). The work is most often cited by research in Pharmaceutical Science (256 citations), Physical and Theoretical Chemistry (118 citations), Spectroscopy (93 citations), Analytical Chemistry (52 citations) and Materials Chemistry (236 citations). Chad Dalton has collaborated with scholars based in Canada and United States. Frequent co-authors include Bruno C. Hancock, Sophie‐Dorothée Clas, Michael J. Pikal, Sheri L. Shamblin, Robert Hartman, Elizabeth Kwong, Robert M. Wenslow, Narayan Variankaval, Roy Helmy and Jerry A. Murry. Their work appears in journals such as Journal of Pharmaceutical Sciences, Pharmaceutical Research, Pharmaceutical Development and Technology, International Journal of Pharmaceutics and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.